Cloudinary Introduces Cloudinary Model Context Protocol (MCP) Server and AI-ready Documentation

SAN JOSE, Calif.--(BUSINESS WIRE)-- Cloudinary, the image and video platform that powers many of the world's top brands, today announced the Cloudinary Model Context Protocol (MCP) Server, AI-ready documentation and a new integration with Base44. The MCP Server allows AI agents and LLMs like Base44, Claude, Cursor and others to easily interact with Cloudinary's image and video APIs and award-winning documentation using natural language. This enables developers and builders alike to turn time-consuming yet business-critical work into lightning fast builds and actions, accelerating development time from days or weeks to minutes.
The company's AI-ready documentation feeds LLMs with an authoritative source on what Cloudinary's APIs can enable and allows developers to build quickly and with confidence. This also offers builders access to Cloudinary without necessarily having to write a single line of code. Using their preferred LLMs, developers and no-code builders can manage their visual media, orchestrate advanced workflows, and prepare assets for relevant channels.
The combination of the Cloudinary Server and its AI-ready documentation provides access to a wide range of Cloudinary's capabilities, enabling users to simplify a variety of image- and video-related tasks such as bulk tagging and organizing and batch cropping, resizing, and overlaying. What's more, Cloudinary supports the creation of very accurate transformations while minimizing the risk of hallucinations. Whether it's a developer looking to streamline complex media workflows or improve cross-team collaboration, or a non-technical builder new to visual asset management building an app or visual-rich experience, Cloudinary provides the intelligence to work smarter and more efficiently without coding or the need for additional integrations.
Cloudinary's Base44 integration empowers builders using Base44 with seamless access to Cloudinary's media transformations, optimization, and delivery tools directly within their agent-driven workflows, enabling faster, more visual, and scalable application development.
'Cloudinary was founded by developers for developers and MCP Server is just our latest commitment to ensuring developers and builders have the tools they need to build the visual-first experiences and apps they dream about – faster and more easily than ever before,' said Tal Lev-Ami, Co-founder and CTO, Cloudinary. 'This new era of LLM-powered code generation underscores the importance of open, API-first platforms and tools designed to empower users to build within flexible yet trusted frameworks and models.'
AI-powered development since day one
API-first and trusted by millions of developers and creators worldwide, Cloudinary has been AI-powered since its inception. For more than a decade, Cloudinary has empowered developers and brands to automate business-critical visual media tasks to ensure their visual-first experiences are fast, flawless and relevant no matter where or how audiences are engaged. In the last 12 months, Cloudinary has launched dozens of AI tools and enhancements including AI Vision and generative AI tools including Generative Fill and Generative Upscale.
Builders are encouraged to join the Cloudinary community and show off their projects with the #BuiltWithCloudinary tag. This summer, Cloudinary will host an MCP Server Challenge for developers and builders. All Cloudinary users will be invited to participate and eligible to win prizes.
The Cloudinary MCP Server is available to all developers and builders and can be accessed via any Cloudinary account or plan, including Cloudinary's free plan. Learn more in today's blog and by visiting the Cloudinary website, and start building today.
About Cloudinary
Cloudinary is the image and video platform that enables the world's most engaging brands to deliver transformative visual experiences at a global scale. More than two million users and 10,000 customers, including Adidas, Bleacher Report, Etsy, Fiverr, Grubhub, Minted and Paul Smith rely on Cloudinary to bring their campaigns, apps and sites to life. Backed by an ecosystem of more than 300 partners, integrations and plug-ins, Cloudinary's AI-powered image and video solutions offer a single source of truth for brands to manage, transform, optimize, and deliver engaging visual content to anyone, anywhere. As a result, brands across all industries are seeing up to a 203% ROI with benefits including faster time to market, higher user satisfaction and increased engagement and conversions. For more information, visit www.cloudinary.com.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

TechCrunch

6 hours ago

• TechCrunch

Week in Review: Meta reveals its Oakley smart glasses

Welcome back to Week in Review! Lots in store for you today, including Wix's latest acquisition, Meta's new smart glasses, a look at the new Digg, and much more. Have a great weekend! Smart specs: Meta and Oakley have teamed up on a new pair of smart glasses that can record 3K video, play music, handle calls, and respond to Meta AI prompts. They start at $399 and have double the battery life of Meta's Ray-Bans. A $499 limited-edition Oakley Meta HSTN model will be available starting July 11. Unicorn watch: Wix bought 6-month-old solo startup Base44 for $80 million in cash after it quickly gained traction as a no-code AI tool for building web apps. Created by a single founder and already profitable, Base44's rapid rise made scooping it up irresistible. Sand to the rescue: Finland just turned on the world's largest sand battery — yes, actual sand — which stores heat to help power the small town of Pornainen's heating system and cut its carbon emissions. The low-tech, low-cost system is built from discarded fireplace soapstone, is housed in a giant silo, and can store heat for weeks, proving you don't need fancy lithium to fight climate change. You just need a pile of hot rocks. This is TechCrunch's Week in Review, where we recap the week's biggest news. Want this delivered as a newsletter to your inbox every Saturday? Sign up here. News Image Credits:Rebecca Bellan We're back, baby: VanMoof is back from the brink with the S6, its first e-bike since bankruptcy — and it's sticking to its signature custom design, despite that being what nearly killed the company. Backed by McLaren tech and a beefed-up repair network, the new VanMoof promises smoother rides, smarter features, and (hopefully) fewer stranded cyclists. Space lasers: Baiju Bhatt, best known for co-founding Robinhood, is now building lasers in space. His new startup, Aetherflux, has raised $60 million to prove that beaming solar power from orbit isn't a fantasy, with a demo satellite set to launch next year and early backing from the Department of Defense. Techcrunch event Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Save $200+ on your TechCrunch All Stage pass Build smarter. Scale faster. Connect deeper. Join visionaries from Precursor Ventures, NEA, Index Ventures, Underscore VC, and beyond for a day packed with strategies, workshops, and meaningful connections. Boston, MA | REGISTER NOW Oh no: One of SpaceX's Starship rockets exploded during a test in Texas, likely pushing back the vehicle's next launch, which had been tentatively set for June 29. SpaceX says the blast, caused by a pressurized tank failure, didn't injure anyone, but it's yet another setback in a rocky year for the company's ambitious mega-rocket program. That lossless feeling: Spotify's long-awaited lossless audio tier still hasn't launched, but fresh hints buried in the latest app code suggest that it's under active development and could be closer than ever. But with years of delays and no official timeline, fans might want to temper their excitement until Spotify confirms the rollout. I can Digg it: Digg's reboot has entered alpha testing with a fresh iOS app aimed at becoming an AI-era Reddit alternative. The app offers a clean, simple design with curated communities, AI-powered article summaries, and gamified features like 'Gems' and daily leaderboards. We want you: The U.S. Navy is speeding up how it works with startups, cutting red tape and zeroing in on real wins like saved time and better morale. Department of the Navy CTO Justin Fanelli says it's leading with problems, hunting for game-changing tech in AI, GPS, and system upgrades. And with Silicon Valley finally paying attention, the Navy's becoming a go-to partner for innovators ready to shake things up. Cash ain't king: Mark Zuckerberg is throwing out massive cash — up to $100 million — to lure top AI talent from OpenAI and DeepMind. But OpenAI's Sam Altman says none of his key people have bitten, praising his team's mission over money. Meanwhile, OpenAI keeps pushing ahead with new AI models and even hints at launching an AI-powered social app that could outpace Meta's own shaky attempts. Before you go Image Credits:Cluely San Francisco's latest startup saga? Cluely's after-party for YC's AI Startup School blew up on Twitter, drawing 2,000 party crashers, but it became the 'most legendary party that never happened' after getting shut down by cops before a single drink was spilled. Founder Roy Lee's viral marketing may have promised chaos, but the real party's waiting. Maybe once the weather warms up?

Business Wire

11 hours ago

• Business Wire

GE HealthCare drives innovation in theranostics with latest technological advances

CHICAGO--(BUSINESS WIRE)--At this year's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE HealthCare is spotlighting the future of precision care with its innovative portfolio of theranostics-enabling solutions designed to help drive clinical and operational excellence. Making its debut, GE HealthCare's MIM Software introduces LesionID Pro with automated zero-click pre-processing i – an AI-powered innovation to help aid physician decision making and therapy response monitoring. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief Share With cancer accounting for over 10 million deaths globally each year, ii the rise of precision care – particularly theranostics – is offering new hope to patients. By combining advanced diagnostic imaging and radiopharmaceuticals with targeted therapies, theranostics enables a personalized, patient-centric approach that may help improve disease detection, treatment accuracy, and overall quality of life. 'Precision care is the future of oncology—and theranostics is at the heart of that future. The integration of advanced imaging and AI-powered software is accelerating the adoption of theranostics in clinical practice,' shares Shyam Srinivas, MD, PhD, Chief of Nuclear Medicine, Associate Clinical Professor, Department of Radiological Sciences, University of California, Irvine. 'With tools like GE HealthCare's Omni Legend, StarGuide, and MIM software at our disposal, we now have the ability to visualize disease with great clarity, quantify tumor burden efficiently, and make fast, informed decisions. These advancements are not only helping enhance diagnostic accuracy and therapy monitoring but are also opening the door to dosimetry—ultimately helping improve outcomes for our patients. This is precision care in action, and it's making a real difference in patients' lives.' Central to the practice of theranostics is molecular imaging, such as positron emission tomography (PET) and single photon emission computed tomography (SPECT), which provides detailed, patient-specific insights to guide and monitor treatment. However, accessing these insights – like whole-body tumor burden, which represents the total amount of cancer is in the body – has traditionally required time-consuming manual analysis, resulting in clinical and operational challenges. In response, GE HealthCare's MIM Software is introducing LesionID Pro with automated zero-click pre-processing, i designed with AI-powered automation to help physicians access reliable whole-body tumor burden statistics without having to spend hours manually segmenting lesions, removing normal physiologic uptake, and registering multiple patient images for comparison. In addition to turning manual pre-processing into a zero-click experience, this new version of LesionID Pro comes with significant algorithm improvements that provide physicians with a precise whole-body tumor volume to review and finalize. Intuitive, user-friendly tools were intentionally designed with input from leading theranostics practitioners with the ultimate goal of making whole-body tumor burden analysis a practical clinical reality and help shorten physicians' time-to-report. 'At GE HealthCare, we are dedicated to providing clinicians the precision care tools needed for the adoption and practice of theranostics,' shares Jean-Luc Procaccini, President & CEO, Molecular Imaging & Computed Tomography, GE HealthCare. 'We designed our portfolio of precision care solutions to evolve with healthcare system needs and help support a patient's entire care journey – from the imaging equipment needed for a noninvasive look at a patient's anatomy and treatment monitoring, to novel radiopharmaceuticals used to diagnose and monitor disease and the systems required to produce them, to the software optimized to enable data-driven decision-making. In the hands of clinicians, these tools help advance the global practice of personalized medicine and help improve patient outcomes.' Also on display at #SNMMI25, as part of GE HealthCare's comprehensive portfolio of theranostics-enabling solutions for clinical and operational excellence, are the following innovations: MINItrace Magni, iii GE HealthCare's newest cyclotron technology, designed with a small footprint (about the size of a commercial refrigerator) and the goal of providing an easy-to-site, easy-to-install solution for the reliable, in-house production of commercial PET tracers and radiometals, including Gallium-68, used in diagnostic imaging to support personalized care plans. Adoption of such easy-to-site, easy-to-install technology may help enhance the capabilities of the healthcare system but also grant clinicians the ability to offer a variety of tracers to their patients and encourage the practice of precision care locally, helping fuel inhouse Theranostics capabilities. Omni Legend is a performance-focused PET/CT designed to evolve and help meet growing healthcare system demands by enabling clinicians to reduce dose by up to 40% iv while maintaining exceptional image quality. Supportive of the diagnostic portion of theranostics, the system continues to gain in popularity, representing the company's fastest-ever-selling PET/CT. v StarGuide is a digital SPECT/CT with a 12 CZT detector design that delivers high-quality 3D images and short scan times. Optimized for certain theranostic procedures, the system is designed to help clinicians pinpoint the size, shape, and position of lesions and monitor therapy with exceptional precision. Its flexibility in patient scanning and workflow efficiencies also support high patient throughput and help reduce complexity. For oncology patients, especially those in pain, short scans can help enhance comfort and overall experience. Aurora is an advanced dual-head SPECT/CT designed with excellent diagnostic capabilities vi and streamline workflows, offering clinicians excellent image quality and operational efficiency. Its CT has a 40 mm detector – twice the detector coverage compared to CTs of other hybrid systems vii – with the ability to reduce the dose up to 82%, viii support accurate quantitation, and help clinicians make the personalized care decisions that are at the heart of theranostics. Theranostics Pathway Manager Tile is an easy-to-use application, available on GE HealthCare's Command Center software, that is designed to simplify the time-consuming task of coordinating the theranostics care pathway. It does so by tracking patient readiness for therapy, eliminating the need for manual data gathering across disparate systems (e.g., labs, scheduling, ordering, spreadsheets), and providing a unified, up-to-date view of each patient's treatment journey. Oregon Health & Science University will be an early adopter. 'Every day counts when it comes to cancer care. The latest theranostics solutions will help our care teams more quickly and easily keep tabs on patient readiness and reduce patient coordination time—freeing up more time for clinicians to focus on direct patient care,' says Erik Mittra, M.D., Ph.D., professor of diagnostic radiology in the at Oregon Health & Science University. Altogether, GE HealthCare has the unique ability to provide solutions along every step of the theranostics care pathway. Our integrated portfolio of solutions provides clinicians with the isotopes, imaging, informatics, and molecular imaging agents necessary for the practice and advancement of precision care. For more information on GE HealthCare's innovative portfolio of theranostics-enabling solutions, please visit SNMMI show attendees are also encouraged stop by the company's booth (#638 and #1023) at New Orleans Ernest N. Morial Convention Center in New Orleans, Louisiana from June 21-24. About GE HealthCare Technologies Inc. GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient's journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits. GE HealthCare is proud to be among 2025 Fortune World's Most Admired Companies™. Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website for more information. i LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region. ii Cancer. World Health Organization. Published February 3, 2022. Accessed March 2, 2023. iii Technology in development that represents ongoing research and development efforts. These technologies are not products and may never become products. Not CE marked. iv Omni Legend 21cm as compared to Discovery MI Gen1 20cm. As demonstrated in phantom testing. v Based on orders data of GE HealthCare PET/CT systems since 2010. vi Compared to NM/CT 870 DR. vii As compared to NM/CT 870 DR with Optima 540 CT. viii a ASiR-V reduces dose by 50% to 82% relative to FBP at the same image quality (Image quality as defined by low contrast detectability). viii b In clinical practice, the use of ASiR‐V may reduce CT patient dose depending on the clinical task, patient size, anatomical location, and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose to obtain diagnostic image quality for the particular clinical task. Low Contrast Detectability (LCD), Image Noise, Spatial Resolution and Artifact were assessed using reference factory protocols comparing ASiR‐V and FBP. The LCD was measured using 0.625 mm slices and tested for both head and body modes using the MITA CT IQ Phantom (CCT183, The Phantom Laboratory), using a model observer method.

Business Wire

a day ago

• Business Wire

EMEREN GROUP INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Emeren Group Ltd.

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Emeren Group Ltd. (NYSE: SOL) to Shurya Vitra Ltd. Under the terms of the proposed transaction, shareholders of Emeren Group will receive $0.20 in cash per ordinary share or $2.00 in cash per American Depositary Share. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit